Ana Muñoz Sánchez

Ana Muñoz Sánchez

Auto-generated profile, based on publicly available information

Ana Muñoz Sánchez

Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Journal Of Nephrology
Verified
Journal Article
Open access
PDF file
AMAna Muñoz-Sánchez
Ana Muñoz-Sánchez
LRLEYRE MARTIN RODRIGUEZ
LEYRE MARTIN RODRIGUEZ
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
MRMaria Valdenebro Recio
Maria Valdenebro Recio
MSMaria Luisa Serrano-Salazar
Maria Luisa Serrano-Salazar
JPJosé Portoles
José Portoles
Background: Acute Kidney Injury (AKI) is frequent and is associated with adverse outcomes. Aims: To analyze the impact of community-acquired and hospital-acquired AKI on in-hospital and five-year post-discharge kidney replacement therapy (KRT) requirement in the pre-COVID era. Methods: We linked the regional health system database of 419,851 admissions to the regional KRT registry. We grouped all admissions into 3 categories: community-acquired AKI, where AKI was the primary diagnosis, and hospital-acquired AKI, where AKI was an additional diagnosis alongside another primary condition. Admissions without this code were grouped into a third category (no AKI). We excluded patients aged under 18 years old, those with previous KRT, and pregnant women. The study was approved by the ethics committee. Patients were followed up for five years after discharge. Results: Community-acquired AKI accounted for 0.6% of all admissions, associated prolonged average hospital stays, and increased mortality rates. In-hospital KRT administration was required in 3.1% of cases, and after a mean follow-up time of 459 days, 7.2% of these patients began chronic KRT. Hospital-acquired AKI represented 6.1% of all admissions and was associated with the highest mortality rate (22.9% vs 14.4% in the community-acquired AKI group) and the longest average hospital stay (12.6 days vs 7.1 in the no AKI group). Only 0.5% of hospital-acquired AKI cases required KRT during the AKI episode, while 2% of these patients initiated chronic KRT after a mean follow-up time of 594 days. Conclusions: AKI continues to be a frequent problem in clinical practice, negatively influencing patient morbidity and mortality, and increasing the risk of starting KRT in the medium-long term. Graphical

27 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MRMaria Valdenebro Recio
Maria Valdenebro Recio
JPJosé Portoles
José Portoles
MSMaría Luisa Serrano Salazar
María Luisa Serrano Salazar
ASAna Muñoz Sánchez
Ana Muñoz Sánchez
IAInes Alameda-Aguado
Ines Alameda-Aguado
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
Introduction: Acute kidney injury (AKI) significantly disrupts vital renal functions and is a common and serious condition in intensive care units (ICUs). AKI leads to extended hospital stays, increases mortality rates, and often necessitates nephrology consultations. Continuous renal replacement therapy (CRRT) plays a central role in managing AKI, requiring a multidisciplinary approach involving nephrologists, intensivists, and anesthesiologists. This study examines the clinical profile and progression of AKI in ICU patients requiring CRRT, with a focus on CRRT indications and modalities. Materials and Methods: We conducted a single-center retrospective observational study on ICU patients with AKI requiring CRRT from January to December 2019. AKI diagnosis followed the RIFLE criteria, and patients who received CRRT for less than 36 h were excluded. Data collected included demographics, hemodynamic parameters, and renal function parameters, with follow-ups at 1 week, 1 month, 6 months, and 12 months. Statistical analyses evaluated outcomes and transitions between CRRT and other renal replacement therapies. Results: Among 123 evaluated patients, 95 met inclusion criteria. Fifteen patients received CRRT for less than 36 h, with an early mortality rate of 80%. The final cohort comprised 80 patients who underwent CRRT for over 36 h, with a mean age of 65.3 years (SD = 13.6) and a Charlson index of 6.4. Patients were categorized based on primary diagnosis into heart failure, cardiac surgery, sepsis, other surgeries, and miscellanea groups. Mortality rates were highest in the heart failure and miscellanea groups. Significant variability was observed in therapy transitions and long-term outcomes. Continuous venovenous hemodiafiltration (CVVHDF) was the most frequently used CRRT modality. Conclusions: This study highlights the variability in CRRT practices and the poor prognosis for critically ill patients with AKI requiring CRRT. Timely nephrology consultation and tailored treatment plans may improve patient outcomes and optimize CRRT utilization. Future research should focus on refining CRRT protocols and exploring preventive strategies for AKI.

1 January 2022 in Transplantation Proceedings
Verified
Journal Article
Closed access
ASAna Muñoz Sánchez
Ana Muñoz Sánchez
TSTeresa Vázquez Sánchez
Teresa Vázquez Sánchez
RARafael del Pozo Alvarez
Rafael del Pozo Alvarez
EVElena Gutierrez Vilchez
Elena Gutierrez Vilchez
MLMyriam Leon
Myriam Leon

20 August 2026 in Nefrología
Verified
Journal Article
Open access
EMEstefanya Garcia Menendez
Estefanya Garcia Menendez
JPJosé Portoles
José Portoles
JFJosé Carlos De La Flor
José Carlos De La Flor
ASAna Muñoz Sánchez
Ana Muñoz Sánchez
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
MFMaría Jose Fernández-Reyes
María Jose Fernández-Reyes